Tapering and Discontinuation of Glucocorticoid Prophylaxis during Prolonged Weekly to Biweekly Paclitaxel Administration

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|116-119

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 116-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stewart-Treves Syndrome: Questionable Response to Weekly Paclitaxel

By  

Chemotherapy, Vol. 56, Iss. 1, 2010-02 ,pp. : 66-68

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

Bioadhesive Drug Delivery System Using Glyceryl Monooleate for the Intravesical Administration of Paclitaxel

By  

Chemotherapy, Vol. 51, Iss. 6, 2005-11 ,pp. : 311-318

Karger

Access to resources Recommend Favorite

Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia

By Noguchi Kevin K.  

Cells, Vol. 3, Iss. 1, 2014-01 ,pp. : 36-52

MDPI

Access to resources Recommend Favorite

A Phase II Study Directed by a Clinical Pathway for Carboplatin and Weekly Paclitaxel in Previously Untreated Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 56, Iss. 1, 2010-02 ,pp. : 39-45

Karger

Access to resources Recommend Favorite